UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 491

Sortiert nach

Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation

Gastroenterology (New York, N.Y. 1943), 2015, Vol.148 (1), p.108-117

2015

Volltextzugriff (PDF)

Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study

Gastroenterology (New York, N.Y. 1943), 2015, Vol.148 (1), p.100-107.e1

2015

Volltextzugriff (PDF)

Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent

Journal of hepatology, 2015-09, Vol.63 (3), p.564-572

2015

Volltextzugriff (PDF)

Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled Study

Gastroenterology (New York, N.Y. 1943), 2007-05, Vol.132 (5), p.1746-1756

2007

Volltextzugriff (PDF)

Severe hepatitis B reactivation during direct-acting antiviral treatment in “the absence” of hepatitis B surface antigen

International journal of infectious diseases, 2019-02, Vol.79, p.47-49

2019

Volltextzugriff (PDF)

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

Hepatology (Baltimore, Md.), 2002-10, Vol.36 (4), p.986-992

2002

Volltextzugriff (PDF)

Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study

Journal of hepatology, 2009-04, Vol.50 (4), p.719-728

2009

Volltextzugriff (PDF)

Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry)

Journal of rheumatology, 2009-07, Vol.36 (7), p.1442

2009

Volltextzugriff (PDF)

Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients

Gastroenterology (New York, N.Y. 1943), 2004-11, Vol.127 (5), p.1347-1355

2004

Volltextzugriff (PDF)

Hepatitis C virus kinetics during and immediately after liver transplantation

Hepatology (Baltimore, Md.), 2002-03, Vol.35 (3), p.680-687

2002

Volltextzugriff (PDF)

Clinical trial watch: Reports from the AASLD Liver Meeting®, Boston, November 2014

Journal of hepatology, 2015-05, Vol.62 (5), p.1196-1203

2015

Volltextzugriff (PDF)

HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates

JHEP reports, 2022-12, Vol.4 (12), p.100580-100580, Article 100580

2022

Volltextzugriff (PDF)

Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period

Journal of hepatology, 2013-03, Vol.58 (3), p.415-420

2013

Volltextzugriff (PDF)

Host phosphatidic acid phosphatase lipin1 is rate limiting for functional hepatitis C virus replicase complex formation

PLoS pathogens, 2018-09, Vol.14 (9), p.e1007284-e1007284

2018

Volltextzugriff (PDF)

Usefulness of liver stiffness measurement during acute cellular rejection in liver transplantation

Liver transplantation, 2016-03, Vol.22 (3), p.298-304

2016

Volltextzugriff (PDF)

Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearance

eLife, 2021-11, Vol.10

2021

Volltextzugriff (PDF)

Incidence of depression in patients with hepatitis C treated with direct-acting antivirals

Revista brasileira de psiquiatria, 2020-01, Vol.42 (1), p.72

2020

Volltextzugriff (PDF)

Longitudinal liver stiffness assessment in patients with chronic hepatitis C undergoing antiviral therapy

PloS one, 2012-10, Vol.7 (10), p.e47715-e47715

2012

Volltextzugriff (PDF)

Influence of language barrier and cultural background in hepatitis B disease knowledge in a Chinese community of Spain

Frontiers in public health, 2024-04, Vol.12, p.1324336-1324336

2024

Volltextzugriff (PDF)

Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies

PloS one, 2016-01, Vol.11 (1), p.e0145409

2016

Volltextzugriff (PDF)

Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free Therapy

Frontiers in immunology, 2020-02, Vol.11, p.129-129

2020

Volltextzugriff (PDF)

Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation

Hepatology (Baltimore, Md.), 2004-09, Vol.40 (3), p.699-707

2004

Volltextzugriff (PDF)

Community-based screening enhances hepatitis B virus linkage to care among West African migrants in Spain

Communications medicine, 2023-12, Vol.3 (1), p.182-182, Article 182

2023

Volltextzugriff (PDF)

EASL Recommendations on Treatment of Hepatitis C 2015

Journal of hepatology, 2015-07, Vol.63 (1), p.199-236

2015

Volltextzugriff (PDF)

1 – 25 von 491

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(482)
Mit Volltextzugriff
(461)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(290)
Life Sciences & Biomedicine
(276)
Humans
(244)
Gastroenterology & Hepatology
(181)
Female
(137)
Male
(136)
Middle Aged
(123)
Antiviral Agents - Therapeutic Use
(98)
Hepatitis C
(92)
Adult
(85)
Hepatitis C Virus
(74)
Liver Transplantation
(74)
Aged
(70)
Hepacivirus - Genetics
(69)
Hepatitis C, Chronic - Drug Therapy
(68)
Biological And Medical Sciences
(65)
Gastroenterology And Hepatology
(65)
Medical Sciences
(62)
Hepatitis
(61)
Infectious Diseases
(60)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(154)
Gastroenterología Y Hepatología
(42)
Hepatology
(37)
Gastroenterology
(25)
Liver International
(16)
Plos One
(14)
The American Journal Of Gastroenterology
(13)
Liver Transplantation
(9)
Enfermedades Infecciosas Y Microbiología Clínica
(8)
Gut
(8)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation

Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study

Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled Study

Severe hepatitis B reactivation during direct-acting antiviral treatment in “the absence” of hepatitis B surface antigen

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study

Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry)

Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients

Hepatitis C virus kinetics during and immediately after liver transplantation

Clinical trial watch: Reports from the AASLD Liver Meeting®, Boston, November 2014

HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates

Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period

Host phosphatidic acid phosphatase lipin1 is rate limiting for functional hepatitis C virus replicase complex formation

Usefulness of liver stiffness measurement during acute cellular rejection in liver transplantation

Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearance

Incidence of depression in patients with hepatitis C treated with direct-acting antivirals

Longitudinal liver stiffness assessment in patients with chronic hepatitis C undergoing antiviral therapy

Influence of language barrier and cultural background in hepatitis B disease knowledge in a Chinese community of Spain

Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies

Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free Therapy

Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation

Community-based screening enhances hepatitis B virus linkage to care among West African migrants in Spain

EASL Recommendations on Treatment of Hepatitis C 2015

Suchergebnisse filtern